Hongpei Tan
-
- Cancer Research and Treatments 2
-
- Immune Cell Function and Interaction 4
- IL-33, ST2, and ILC Pathways 2
-
- Nanoplatforms for cancer theranostics 3
-
- Radiomics and Machine Learning in Medical Imaging 2
-
- Eosinophilic Esophagitis 2
-
- Ferroptosis and cancer prognosis 2
-
- Cancer Immunotherapy and Biomarkers 2
- Journals
- Scientific Reports (1 paper)Science Translational Medicine (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- ChinaUnited StatesMalaysia
In The Last Decade
Hongpei Tan
17 papers receiving 148 citations
Peers
Comparison fields: 5 of 56
- Biotechnology 27
- Microbiology 11
- Health Informatics 2
- Biomaterials 15
- Anesthesiology and Pain Medicine 6
Countries citing papers authored by Hongpei Tan
This map shows the geographic impact of Hongpei Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongpei Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongpei Tan more than expected).
Fields of papers citing papers by Hongpei Tan
This network shows the impact of papers produced by Hongpei Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongpei Tan. The network helps show where Hongpei Tan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hongpei Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 6 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 15 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 16 | |
| 11 | 2022 | 54 | |
| 12 | 2022 | 4 | |
| 13 | 2022 | 4 | |
| 14 | 2021 | 4 | |
| 15 | 2020 | 1 | |
| 16 | 2019 | 18 | |
| 17 | 2018 | 5 | |
| 18 | 2015 | 9 |
About Hongpei Tan
Hongpei Tan is a scholar working on Health Informatics, Pulmonary and Respiratory Medicine and Biotechnology, having authored 18 papers that have together received 150 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (4 papers), Nanoplatforms for cancer theranostics (3 papers), Radiomics and Machine Learning in Medical Imaging (2 papers), Cancer Research and Treatments (2 papers), Eosinophilic Esophagitis (2 papers), IL-33, ST2, and ILC Pathways (2 papers), Ferroptosis and cancer prognosis (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Biotechnology (27 citations), Microbiology (11 citations) and Health Informatics (2 citations). Hongpei Tan has collaborated with scholars based in China, United States and Malaysia. Frequent co-authors include Pengfei Rong, Ze Mi, Jiahao Liu, Wenhu Zhou, Shuo Hu, Zhenguo Liu, Yan Qi, Jinhai Zheng, Yongxiang Tang and Xiaoqian Ma. Their work appears in journals such as Scientific Reports, Science Translational Medicine and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.